Lv1
10 积分 2024-11-10 加入
KRAS inhibitors: resistance drivers and combinatorial strategies
1天前
已完结
Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression
10天前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
1个月前
已完结
Realigned transsulfuration drives BRAF-V600E-targeted therapy resistance in melanoma
1个月前
已完结
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
1个月前
已完结
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
2个月前
已完结
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis
2个月前
已完结
Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
2个月前
已完结
DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening
2个月前
已关闭
CRISPR–Cas9 screening identifies the role of FER as a tumor suppressor
2个月前
已完结
皖公网安备34019202002308
